sulfamic acid has been researched along with 2-amino-3-methylimidazo(4,5-f)quinoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coles, B; Ketterer, B; Skipper, PL; Tannenbaum, SR; Turesky, RJ | 1 |
| Kato, R; Nagata, K; Ozawa, S; Yamazoe, Y | 1 |
| Hsu, FF; Lakshmi, VM; Zenser, TV | 1 |
3 other study(ies) available for sulfamic acid and 2-amino-3-methylimidazo(4,5-f)quinoline
| Article | Year |
|---|---|
Sulfamate formation is a major route for detoxification of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat.
Topics: Animals; Bile; Inactivation, Metabolic; Male; Mutagens; Quinolines; Rats; Rats, Inbred Strains; Sulfonic Acids | 1986 |
Formation of 2-amino-3-methylimidazo[4,5-f]quinoline- and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-sulfamates by cDNA-expressed mammalian phenol sulfotransferases.
Topics: Animals; Arylsulfotransferase; Cell Line; Cytosol; DNA, Complementary; Female; Gene Expression; Kinetics; Liver; Male; Quinolines; Quinoxalines; Rats; Rats, Sprague-Dawley; Sulfonic Acids | 1995 |
Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.
Topics: Administration, Oral; Animals; beta-Naphthoflavone; Biotransformation; Carbon Radioisotopes; Carcinogens; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dealkylation; Ellipticines; Enzyme Inhibitors; Female; Glucuronides; Injections, Intraperitoneal; Metabolomics; Mice; Mice, Inbred C57BL; Microsomes, Liver; Quinolines; Spectrometry, Mass, Electrospray Ionization; Sulfates; Sulfonic Acids; Tandem Mass Spectrometry; Theophylline | 2009 |